Financial Performance1Q EBITDA of $131M was ahead of consensus, with impressive revenue rising 25.9%, largely on strength across Pharmacy Solutions.
Growth PotentialThe company sounded bullish coming out of a strong Q1 and reiterated its long-term growth target in the mid-teens driven by the attractive organic growth for every service line, enhanced by acquisitions.
Market PositionThe mix of services gives BTSG scale benefits in procurement, ability to leverage best practices, as well as position to offer integrated services.
Strategic InitiativesThe company's efforts to reduce leverage have been accelerated by the sale of Rescare, which is part of the company's strategy to improve its financial profile.